New Dosage Regimen Promises Better Compliance for
Treatment of Osteoporosis
The World Health Organization (WHO) recently
declared osteoporosis an "Intolerable Epidemic."
Osteoporosis is a widespread disease that is neglected,
under-diagnosed, and under-treated despite the
availability of effective and well-tolerated treatment
options.
"Osteoporosis is second only to cardiovascular
disease as a leading health care problem. One
woman in three and one man in eight over the age
of 50 will suffer a fracture caused by osteoporosis,
unless they go for treatment," said Professor
Pierre D. Delmas, MD, PhD, Professor of Medicine
and Rheumatology at the Universitè Claude Bernard
of Lyon, France and Director of the INSERM Research
Unit 403 on Pathophysiology of Osteoporosis at
the Hospital Edouard Herriot of Lyon. INSERM is
the French National Institute of Medical Research.
Prof. Delmas, who is also President of the International
Osteoporosis Foundation (IOF), was in Manila recently
to present the results of a clinical study which
evaluated the safety and efficacy of a more convenient
once-weekly dosage schedule in post-menopausal
women with osteoporosis. Prof. Delmas delivered
these findings during the 3rd Annual Meeting of
the Osteoporosis Society of the Philippines Foundation,
Inc. (OSFI) held at the Shangri-La Hotel in Makati
City.
Print
Now!
